Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
复制标题
DOI:
10.1038/ncomms7244
复制
发表时间:
2015-02-18
影响因子:
16.6
通讯作者:
Gersbach, Charles A.
中科院分区:
文献类型:
--
作者:
Ousterout, David G.;Kabadi, Ami M.;Thakore, Pratiksha I.;Majoros, William H.;Reddy, Timothy E.;Gersbach, Charles A.
The CRISPR/Cas9 genome editing platform is a promising technology to correct the genetic basis of hereditary diseases. The versatility, efficiency, and multiplexing capabilities of the CRISPR/Cas9 system enable a variety of otherwise challenging gene correction strategies. Here we use the CRISPR/Cas9 system to restore the expression of the dystrophin gene in cells carrying dystrophin mutations that cause Duchenne muscular dystrophy (DMD). We design single or multiplexed sgRNAs to restore the dystrophin reading frame by targeting the mutational hotspot at exons 45–55 and introducing shifts within exons or deleting one or more exons. Following gene editing in DMD patient myoblasts, dystrophin expression is restored in vitro. Human dystrophin is also detected in vivo after transplantation of genetically corrected patient cells into immunodeficient mice. Importantly, the unique multiplex gene editing capabilities of the CRISPR/Cas9 system facilitate the generation of a single large deletion that can correct up to 62% of DMD mutations.
登录
查看更多内容
影响因子:
7
作者:
Cho SW;Kim S;Kim Y;Kweon J;Kim HS;Bae S;Kim JS
通讯作者:
Kim JS
影响因子:
46.9
作者:
通讯作者:
--
影响因子:
16.6
作者:
通讯作者:
--
影响因子:
17.3
作者:
Gaj, Thomas;Gersbach, Charles A.;Barbas, Carlos F., III
通讯作者:
Barbas, Carlos F., III
影响因子:
158.5
作者:
Goemans, Nathalie M.;Tulinius, Mar;van Deutekom, Judith C.
通讯作者:
van Deutekom, Judith C.